BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10993018)

  • 21. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A better way to predict cardiovascular risk. We know how important cholesterol levels are, but what about inflammation?
    Harv Womens Health Watch; 2007 Apr; 14(8):1-2. PubMed ID: 17441261
    [No Abstract]   [Full Text] [Related]  

  • 23. [C-reactive protein in cardiovascular diseases].
    Lubas W; Gutkowski K
    Przegl Lek; 2006; 63(7):562-6. PubMed ID: 17203810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
    Hodkova M; Dusilova-Sulkova S; Kalousova M; Soukupova J; Zima T; Mikova D; Malbohan IM; Bartunkova J
    Ren Fail; 2006; 28(5):395-9. PubMed ID: 16825088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein: "cutoff" point and clinical applicability.
    Tsirpanlis G; Alevyzaki F; Triantafyllis G; Chatzipanagiotou S; Nicolaou C
    Am J Kidney Dis; 2005 Aug; 46(2):368; author reply 369. PubMed ID: 16112061
    [No Abstract]   [Full Text] [Related]  

  • 26. Change in cardiovascular risk status after dental clearance.
    Ellis JS; Averley PA; Preshaw PM; Steele JG; Seymour RA; Thomason JM
    Br Dent J; 2007 May; 202(9):543-4. PubMed ID: 17496863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical application of C-reactive protein in prognosis and prevention of cardiovascular disease].
    Feng RF
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1370-3. PubMed ID: 14584491
    [No Abstract]   [Full Text] [Related]  

  • 28. Beyond cholesterol. Inflammation is emerging as a major risk factor--and not just in heart disease.
    Park A
    Time; 2002 Nov; 160(22):74-5. PubMed ID: 12463072
    [No Abstract]   [Full Text] [Related]  

  • 29. IgG is higher in South Asians than Europeans: does infection contribute to ethnic variation in cardiovascular disease?
    Fischbacher CM; Bhopal R; Blackwell CC; Ingram R; Unwin NC; White M; Alberti KG
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):703-4. PubMed ID: 12692011
    [No Abstract]   [Full Text] [Related]  

  • 30. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Circulation; 2005 Aug; 112(7):976-83. PubMed ID: 16087797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease.
    Halvorsen B; Lund Sagen E; Ueland T; Aukrust P; Tonstad S
    Scand J Clin Lab Invest; 2007; 67(6):604-11. PubMed ID: 17852807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein and coronary heart disease.
    Ridker PM; Koenig W; Fuster V
    N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257563
    [No Abstract]   [Full Text] [Related]  

  • 33. C-reactive protein: a new golden marker of cardiovascular risk.
    Gomes MC
    Rev Port Cardiol; 2002 Nov; 21(11):1329-46. PubMed ID: 12564084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein in the prediction of cardiovascular events.
    Lloyd-Jones DM; Levy D
    N Engl J Med; 2003 Mar; 348(11):1059-61; author reply 1059-61. PubMed ID: 12637619
    [No Abstract]   [Full Text] [Related]  

  • 35. Relation of educational level to inflammation-sensitive biomarker level.
    Steinvil A; Shirom A; Melamed S; Toker S; Justo D; Saar N; Shapira I; Berliner S; Rogowski O
    Am J Cardiol; 2008 Oct; 102(8):1034-9. PubMed ID: 18929705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [C-reactive protein--a molecule that changed cardiology].
    Ostádal P
    Vnitr Lek; 2004 Nov; 50(11):809-11. PubMed ID: 15648958
    [No Abstract]   [Full Text] [Related]  

  • 37. [Possible association between serum C-reactive protein concentrations and ischemic heart disease].
    Shapira I; Zeltzer D; Berliner S
    Harefuah; 1999 Aug; 137(3-4):149-53. PubMed ID: 10959309
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism.
    Hueston WJ; King DE; Geesey ME
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):582-7. PubMed ID: 16268812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.
    Haffner SM
    Am J Cardiol; 2006 Jan; 97(2A):3A-11A. PubMed ID: 16442931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple biomarkers for predicting cardiovascular events: lessons learned.
    Wang TJ
    J Am Coll Cardiol; 2010 May; 55(19):2092-5. PubMed ID: 20447531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.